OUTBREAK OF EXTENSIVELY DRUG RESISTANT STENOTROPHOMONAS MALTOPHILIA IN BURN UNIT
AbstractStenotrophomonas maltophiliais an emerging cause of nosocomial infections. We report an outbreak of XDR-Stenotrophomonas maltophilia infection from burn unit of a tertiary care hospital in July 2016. The strain isolated was resistant to all antimicrobials tested but colistin. Outbreak investigation was carried out which subsided after timely intervention. Patients were treated adequately by Colistin.Keywords: Burn unit, Outbreak; Stenotrophomonas maltophilia
Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 2012;25(1):2–41.
Samonis G, Karageorgopoulos DE, Maraki S, Levis P, Dimopoulou D, Spernovasilis NA, et al. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One 2012;7(5):e37375.
Dalamaga M, Karmaniolas K, Chavelas C, Liatis S, Matekovits H, Migdalis I. Stenotrophomonas maltophilia: a serious and rare complication in patients suffering from burns. Burns 2003;29(7):711–3.
Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008;46(7):1121–2.
Guyot A, Turton JF, Garner D. Outbreak of Stenotrophomonas maltophilia on an intensive care unit. J Hosp Infect 2013;85(4):303–7.
Ahn GY, Yu FN, Jang SJ, Kim DM, Park G, Moon DS, et al. Pseudo-outbreak of Stenotrophomonas maltophilia due to contamination of bronchoscope. Korean J Lab Med 2007;27(3):205–9.
Tsai WP, Chen CL, Ko WC, Pan SC. Stenotrophomonas maltophilia bacteremia in burn patients. Burns 2006;32(2):155–8.
Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR. Therapeutic options for Stenotroponas malhomtophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother 2008;62(5):889–94.
Al-Jasser AM. Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem. Ann Clin Microbiol Antimicrob 2006;5:23.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.